The other important biological function shared by trabectedin and the other identified compounds, especially mitomycin-c and SB-218078, is the transcriptional regulation guided by PPARalpha, a pathway that is already possible to target with PPARalpha-agonists, for example in the treatment of metabolic syndromes [27]. The gene discussed is PPARA; the disease is metabolic syndrome.